Emerald Mutual Fund Advisers Trust Acadia Pharmaceuticals Inc Transaction History

Emerald Mutual Fund Advisers Trust

$1.47 Billion
Q2 2025

A detailed history of Emerald Mutual Fund Advisers Trust transactions in Acadia Pharmaceuticals Inc stock. As of the latest transaction made, Emerald Mutual Fund Advisers Trust holds 319,306 shares of ACAD stock, worth $6.8 Million. This represents 0.47% of its overall portfolio holdings.

Number of Shares

319,306

Previous 495,084 35.5%

Holding current value

$6.8 Million

Previous $8.22 Million 16.25%

% of portfolio

0.47%

Previous 0.67%

15 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2025 Aug 04, 2025	SELL	$14.1 - $22.95 $2.48 Million - $4.03 Million	-175,778 Reduced 35.5%	319,306 $6.89 Million
Q1 2025 May 01, 2025	SELL	$16.61 - $20.29 $88,149 - $107,679	-5,307 Reduced 1.06%	495,084 $8.22 Million
Q4 2024 Feb 14, 2025	SELL	$14.29 - $18.76 $1.06 Million - $1.4 Million	-74,419 Reduced 12.95%	500,391 $9.18 Million
Q3 2024 Oct 29, 2024	BUY	$15.14 - $19.14 $241,649 - $305,493	15,961 Added 2.86%	574,810 $8.85 Million
Q2 2024 Aug 06, 2024	SELL	$14.62 - $18.42 $10.1 Million - $12.7 Million	-691,380 Reduced 55.3%	558,849 $9.08 Million
Q1 2024 May 08, 2024	SELL	$17.79 - $30.86 $966,477 - $1.68 Million	-54,327 Reduced 4.16%	1,250,229 $23.1 Million
Q4 2023 Feb 05, 2024	BUY	$20.78 - $31.77 $11,803 - $18,045	568 Added 0.04%	1,304,556 $40.8 Million
Q3 2023 Oct 26, 2023	BUY	$20.84 - $33.47 $268,710 - $431,562	12,894 Added 1.0%	1,303,988 $27.2 Million
Q2 2023 Aug 10, 2023	BUY	$17.8 - $25.65 $1.49 Million - $2.15 Million	83,792 Added 6.94%	1,291,094 $30.9 Million
Q1 2023 May 04, 2023	BUY	$16.32 - $20.92 $2.59 Million - $3.32 Million	158,552 Added 15.12%	1,207,302 $22.7 Million
Q4 2022 Feb 03, 2023	BUY	$14.2 - $18.63 $227,356 - $298,284	16,011 Added 1.55%	1,048,750 $16.7 Million
Q3 2022 Oct 25, 2022	BUY	$14.11 - $18.27 $3.75 Million - $4.86 Million	265,768 Added 34.65%	1,032,739 $16.9 Million
Q2 2022 Jul 29, 2022	BUY	$13.01 - $27.22 $1.52 Million - $3.18 Million	116,978 Added 18.0%	766,971 $10.8 Million
Q1 2022 Apr 29, 2022	SELL	$20.94 - $27.5 $1.21 Million - $1.59 Million	-57,976 Reduced 8.19%	649,993 $15.7 Million
Q4 2021 Feb 02, 2022	BUY	$16.79 - $27.09 $11.9 Million - $19.2 Million	707,969 New	707,969 $16.5 Million

Others Institutions Holding ACAD

# of Institutions

346

Shares Held

163M

Call Options Held

811K

Put Options Held

334K

View Full List

About ACADIA PHARMACEUTICALS INC

Ticker ACAD
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 161,843,008
Market Cap $3.45B
Description
ACADIA Pharmaceuticals Inc., a biopharmaceutical company, focuses on the development and commercialization of small molecule drugs that address unmet medical needs in central nervous system disorders. The company offers NUPLAZID (pimavanserin) for the treatment of hallucinations and delusions associated with Parkinson's disease psychosis. It's p...

More about ACAD

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Emerald Mutual Fund Advisers Trust, based on Form 13F filings with the SEC.

News

Stay updated on Emerald Mutual Fund Advisers Trust with notifications on news.

Account

Emerald Mutual Fund Advisers Trust Acadia Pharmaceuticals Inc Transaction History